Latest Insider Transactions at Icu Medical Inc (ICUI)
This section provides a real-time view of insider transactions for Icu Medical Inc (ICUI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ICU MEDICAL INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ICU MEDICAL INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 06
2022
|
Daniel Woolson VP, GM-Infusion Capital |
SELL
Payment of exercise price or tax liability
|
Direct |
1,267
-6.35%
|
$153,307
$121.46 P/Share
|
|
Mar 06
2022
|
Daniel Woolson VP, GM-Infusion Capital |
BUY
Exercise of conversion of derivative security
|
Direct |
2,862
+12.54%
|
-
|
|
Mar 06
2022
|
Christian B. Voigtlander Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,576
-6.11%
|
$381,392
$242.93 P/Share
|
|
Mar 06
2022
|
Christian B. Voigtlander Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,995
+10.41%
|
-
|
|
Mar 03
2022
|
Vivek Jain Chairman and CEO |
SELL
Open market or private sale
|
Direct |
36,000
-73.8%
|
$8,640,000
$240.0 P/Share
|
|
Mar 03
2022
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
36,000
+42.46%
|
$2,088,000
$58.79 P/Share
|
|
Dec 30
2021
|
Vivek Jain Chairman and CEO |
SELL
Open market or private sale
|
Direct |
1,159
-8.32%
|
$278,160
$240.0 P/Share
|
|
Dec 30
2021
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,159
+7.68%
|
$67,222
$58.79 P/Share
|
|
Dec 29
2021
|
Vivek Jain Chairman and CEO |
SELL
Open market or private sale
|
Direct |
10,677
-45.52%
|
$2,562,480
$240.0 P/Share
|
|
Dec 29
2021
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,677
+31.28%
|
$619,266
$58.79 P/Share
|
|
Dec 28
2021
|
Vivek Jain Chairman and CEO |
SELL
Open market or private sale
|
Direct |
164
-1.27%
|
$39,360
$240.0 P/Share
|
|
Dec 28
2021
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
164
+1.25%
|
$9,512
$58.79 P/Share
|
|
Nov 03
2021
|
Vivek Jain Chairman and CEO |
SELL
Open market or private sale
|
Direct |
24,000
-48.43%
|
$5,760,000
$240.0 P/Share
|
|
Nov 03
2021
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,000
+32.63%
|
$1,392,000
$58.79 P/Share
|
|
Sep 15
2021
|
Robert S Swinney Director |
SELL
Open market or private sale
|
Direct |
2,157
-9.39%
|
$524,151
$243.0 P/Share
|
|
Sep 14
2021
|
George A Lopez Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,295
+5.65%
|
$703,570
$46.53 P/Share
|
|
Sep 14
2021
|
Elisha W Finney |
SELL
Open market or private sale
|
Direct |
2,424
-58.54%
|
$586,608
$242.2 P/Share
|
|
Sep 14
2021
|
Elisha W Finney |
BUY
Exercise of conversion of derivative security
|
Direct |
2,424
+36.92%
|
$244,824
$101.06 P/Share
|
|
Sep 10
2021
|
Virginia Ruth Sanzone VP, General Counsel |
SELL
Open market or private sale
|
Direct |
800
-12.48%
|
$200,800
$251.44 P/Share
|
|
Jun 03
2021
|
Robert S Swinney Director |
SELL
Open market or private sale
|
Direct |
4,500
-3.46%
|
$913,500
$203.26 P/Share
|
|
Jun 03
2021
|
Robert S Swinney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+5.32%
|
$123,000
$41.5 P/Share
|
|
May 24
2021
|
Vivek Jain Chairman and CEO |
SELL
Bona fide gift
|
Direct |
40
-0.31%
|
-
|
|
May 20
2021
|
Vivek Jain Chairman and CEO |
SELL
Bona fide gift
|
Direct |
25
-0.19%
|
-
|
|
May 11
2021
|
Elisha W Finney |
BUY
Exercise of conversion of derivative security
|
Direct |
468
+19.35%
|
-
|
|
May 11
2021
|
Virginia Ruth Sanzone VP, General Counsel |
SELL
Open market or private sale
|
Direct |
983
-29.01%
|
$196,600
$200.11 P/Share
|
|
May 11
2021
|
David C. Greenberg Director |
BUY
Exercise of conversion of derivative security
|
Direct |
468
+12.86%
|
-
|
|
May 11
2021
|
Robert S Swinney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
468
+1.88%
|
-
|
|
May 11
2021
|
Donald Abbey |
BUY
Exercise of conversion of derivative security
|
Direct |
468
+28.73%
|
-
|
|
May 11
2021
|
David F Hoffmeister |
BUY
Exercise of conversion of derivative security
|
Direct |
468
+28.73%
|
-
|
|
Apr 23
2021
|
George A Lopez Director |
SELL
Open market or private sale
|
Indirect |
13,015
-0.36%
|
$2,772,195
$213.32 P/Share
|
|
Apr 22
2021
|
George A Lopez Director |
SELL
Open market or private sale
|
Indirect |
11,985
-0.44%
|
$2,564,790
$214.5 P/Share
|
|
Apr 16
2021
|
George A Lopez Director |
SELL
Open market or private sale
|
Indirect |
10,100
-0.18%
|
$2,121,000
$210.34 P/Share
|
|
Apr 15
2021
|
George A Lopez Director |
SELL
Open market or private sale
|
Indirect |
14,900
-0.4%
|
$3,099,200
$208.08 P/Share
|
|
Apr 12
2021
|
George A Lopez Director |
SELL
Open market or private sale
|
Indirect |
4,700
-0.17%
|
$968,200
$206.04 P/Share
|
|
Apr 09
2021
|
George A Lopez Director |
SELL
Open market or private sale
|
Indirect |
10,400
-0.37%
|
$2,111,200
$203.88 P/Share
|
|
Apr 08
2021
|
George A Lopez Director |
SELL
Open market or private sale
|
Indirect |
9,900
-0.34%
|
$2,019,600
$204.07 P/Share
|
|
Apr 05
2021
|
George A Lopez Director |
SELL
Open market or private sale
|
Indirect |
10,200
-0.21%
|
$2,101,200
$206.14 P/Share
|
|
Apr 01
2021
|
George A Lopez Director |
SELL
Open market or private sale
|
Indirect |
14,800
-0.25%
|
$3,063,600
$207.11 P/Share
|
|
Mar 31
2021
|
Robert S Swinney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+5.88%
|
$66,000
$44.82 P/Share
|
|
Mar 06
2021
|
Virginia Ruth Sanzone VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,599
-21.13%
|
-
|
|
Mar 06
2021
|
Virginia Ruth Sanzone VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,039
+28.63%
|
-
|
|
Mar 06
2021
|
Daniel Woolson VP, GM-Infusion Capital |
SELL
Payment of exercise price or tax liability
|
Direct |
1,267
-7.56%
|
-
|
|
Mar 06
2021
|
Daniel Woolson VP, GM-Infusion Capital |
BUY
Exercise of conversion of derivative security
|
Direct |
2,862
+14.58%
|
-
|
|
Mar 06
2021
|
Kevin J Mc Grody Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,351
-12.63%
|
-
|
|
Mar 06
2021
|
Kevin J Mc Grody Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,568
+19.33%
|
-
|
|
Mar 06
2021
|
Christian B. Voigtlander Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,194
-6.59%
|
-
|
|
Mar 06
2021
|
Christian B. Voigtlander Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,168
+11.12%
|
-
|
|
Mar 06
2021
|
Vivek Jain Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,103
-7.93%
|
-
|
|
Mar 06
2021
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,897
+12.99%
|
-
|
|
Mar 06
2021
|
Brian Michael Bonnell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,196
-19.17%
|
-
|